Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Polsky Center
AddedFeb 15, 2024
UpdatedJun 28, 2026
Polsky Center

Polsky Center

Operating

UChicago's Polsky Center runs entrepreneurship programs, investing in affiliated teams via NVC and Accelerator.

Location
Chicago, IL, US
Founded
1996
Firm
Compare
Portfolio
Fundraising
Employees
Website

The Polsky Center for Entrepreneurship and Innovation at the University of Chicago focuses on advancing innovative ideas and technologies from the university ecosystem. It invests in UChicago-affiliated teams through programs like the New Venture Challenge (NVC) and the Polsky Center Accelerator Program. The center typically provides grant funding, non-equity assistance, and early-stage investments ranging from pre-seed to seed rounds.

Notable portfolio companies include Amopportunities, demi, and Seurat Therapeutics. The Polsky Center offers comprehensive support for entrepreneurs, including training programs, experiential learning opportunities, and industry-specific accelerators. It places particular emphasis on deep tech ventures, providing business training, technical advisement, and connections to venture capital for early-stage startups.

Polsky Center - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments10
Current Portfolio Count10
Total Portfolio Exits0

Top Investment Stages

Grant3 (30.0%)
Non Equity Assistance3 (30.0%)
Seed2 (20.0%)
Angel1 (10.0%)
Pre-Seed1 (10.0%)

Stage Mix

Grant 30%Non Equity Assistance 30%Seed 20%Angel 10%Pre-Seed 10%

Concentration shown as share of disclosed investments by stage.

Recent Investments

demi logo

demi

Haylon Technologies logo

Haylon Technologies

OrisDX logo

OrisDX

Pippin Title logo

Pippin Title

Seurat Therapeutics logo

Seurat Therapeutics

Amopportunities logo

Amopportunities

Banyan Technologies logo

Banyan Technologies

Markit Medical logo

Markit Medical

HighStride logo

HighStride

Janus Choice logo

Janus Choice

Polsky Center - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 6 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 610000Educational Services
  • 541000Professional, Scientific, and Technical Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified